Registry of Toxic Effects of Chemical Substances (RTECS)
Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-
RTECS #
KH6550000CAS #
151-67-7Updated
September 201Molecular Weight
197.39Molecular Formula
C2HBrClF3Synonyms
1,1,1-Trifluoro-2-bromo-2-chloroethane1,1,1-Trifluoro-2-chloro-2-bromoethane
1-Bromo-1-chloro-2,2,2-trifluoroethane
2,2,2-Trifluoro-1-chloro-1-bromoethane
2-Bromo-2-chloro-1,1,1-trifluoroethane
Bromochlorotrifluoroethane
Chalothane
Ethane, 1-bromo-1-chloro-2,2,2-trifluoro-
Fluorotane
Fluothane
Ftorotan (Russian)
Halotan
Halothane
Halothane (ACGIH)
Halsan
Narcotane
Narcotann NE-spofa (Russian)
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 100 mg | severe | FEPRA7 35,729,1976 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | lymphocyte/human | 1 pph/48H-continuous | NSMZDZ 7,19,1979 |
Cytogenetic Analysis | fibroblast/mouse | 1000 ppm | ENVRAL 12,366,1976 |
Cytogenetic Analysis | lung/hamster | 1 pph/48H-continuous | NSMZDZ 7,19,1979 |
Cytogenetic Analysis | parenteral/chicken | 10 mg | ENVRAL 12,366,1976 |
DNA inhibition | inhalation/mouse | 8000 ppm/24H-continuous | CNREA8 36,3156,1976 |
micronucleus test | oral/rat | 4 mmol/kg | MUREAV 413,1,1998 |
other mutation test systems | inhalation/grasshopper | 46 pph/16H | MUREAV 113,467,1983 |
other mutation test systems | other cell types/non-mammalian species | 1 mmol/L | ECREAL 141,492,1982 |
other mutation test systems | inhalation/mouse | 1 pph/1H | BCPCA6 27,2187,1978 |
other mutation test systems | fibroblast/hamster | 1 pph | ANESAV 43,21,1975 |
sex chromosome loss and nondisjunction | inhalation/Drosophila melanogaster | 1 pph/1H | ANESAV 62,305,1985 |
sex chromosome loss and nondisjunction | oral/Drosophila melanogaster | 3450 ppm/24H-continuous | MUREAV 91,225,1981 |
Unscheduled DNA Synthesis | inhalation/rat | 1000 ppm/2H-continuous | ANESAV 30,401,1969 |
Unscheduled DNA Synthesis | oral/rat | 10 gm/kg | JTEHD6 10,327,1982 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | 100 ppm/8H (2-22D preg/30D after birth) | Reproductive: Effects on newborn: Behavioral | BBREDI 36,147,1990 |
inhalation/rat | 8000 ppm/12H (9D pregnant) | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | ANESAV 29,1167,1968 |
inhalation/rat | 1600 ppm/8H (1-21D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | ANESAV 48,11,1978 |
inhalation/rat | 10 ppm/8H (1-22D pregnant) | Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) Reproductive: Specific developmental abnormalities: Central nervous system | ENVRAL 11,40,1976 |
inhalation/rat | 8000 ppm/6H (7-9D pregnant) | Reproductive: Effects on fertility: Abortion | AAREAV 32,41,1975 |
inhalation/rat | 10 ppm/8H (1-22D pregnant) | Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) Reproductive: Specific developmental abnormalities: Urogenital system | ENVRAL 10,174,1975 |
inhalation/mouse | 3000 ppm/4H (9W prior to copulation/1-21D pregnant) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) Reproductive: Effects on fertility: Other measures of fertility | ANESAV 48,167,1978 |
inhalation/mouse | 1000 ppm/4H (9W prior to copulation/1-21D pregnant) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | ANESAV 48,167,1978 |
inhalation/mouse | 1 pph/3H (13D pregnant) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Other developmental abnormalities | TJADAB 4,242,1971 |
inhalation/mouse | 3000 ppm/4H (9W prior to copulation/1-17D pregnant) | Reproductive: Specific developmental abnormalities: Urogenital system | ANESAV 51,532,1979 |
inhalation/mouse | 14000 ppm/1H (8-10D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | DABBBA 31,3599,1970 |
inhalation/mouse | 15000 ppm/40M (3W prior to copulation) | Reproductive: Other effects on female Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4) Reproductive: Effects on newborn: Other postnatal measures or effects | REPTED 13,361,1999 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/child | lowest published toxic concentration: 0.9 pph | Cardiac: Change in rate Lung, Thorax, or Respiration: Respiratory depression Biochemical: Metabolism (intermediary): Other | AANEAB 45,639,2001 |
inhalation/human | Lowest published lethal concentration: 7000 ppm/3H | Liver: Hepatitis (hepatocellular necrosis), diffuse Gastrointestinal: Nausea or vomiting Nutritional and Gross Metabolic: Body temperature increase | ANESAV 24,29,1963 |
inhalation/mouse | lethal concentration (50 percent kill): 98 gm/m3/2H | Brain and Coverings: Other degenerative changes Liver: Other changes Kidney, Ureter, and Bladder: Other changes | TLSMA6 111,10,1975 |
inhalation/mouse | lethal concentration (50 percent kill): 93600 mg/m3/2H | VCVGH* -,644,1990 | |
inhalation/mouse | lethal concentration (50 percent kill): 340575 mg/m3/10M | VCVGH* -,644,1990 | |
inhalation/mouse | lethal concentration (50 percent kill): 270662 mg/m3/30M | VCVGH* -,644,1990 | |
inhalation/mouse | lethal concentration (50 percent kill): 197421 mg/m3/60M | VCVGH* -,644,1990 | |
inhalation/mouse | lowest published toxic concentration: 1.21 pph/20M | Behavioral: Analgesia | JPETAB 317,615,2006 |
inhalation/mouse | lowest published toxic concentration: 2960.85 mg/kg | Liver: Hepatitis (hepatocellular necrosis), zonal Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases | TOXID9 -,174,2008 |
inhalation/mouse | lowest published toxic concentration: 1.35 pph/20M | Behavioral: General anesthetic | JPETAB 323,924,2007 |
inhalation/rat | lowest published toxic concentration: 10 ppm/2H | Liver: Multiple effects Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases Biochemical: Metabolism (intermediary): Other | TOXID9 227,53,2006 |
inhalation/rat | lethal concentration (50 percent kill): 120000 mg/m3/4H | VCVGH* -,644,1990 | |
inhalation/rat | lowest published toxic concentration: 1.5 pph/30M | Brain and Coverings: Other degenerative changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes Biochemical: Metabolism (intermediary): Other | AANEAB 46,378,2002 |
inhalation/rat | lethal concentration (50 percent kill): 29000 ppm | FATOAO 25,143,1962 | |
inhalation/rat | lowest published toxic concentration: 1.5 pph | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport | FATOAO 55,33,1992 |
intraperitoneal/guinea pig | lowest published toxic dose: 1.97 gm/kg | Liver: Liver function tests impaired Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Other proteins | CRTOEC 14,362,2001 |
intraperitoneal/guinea pig | lowest published toxic dose: 1974 mg/kg | Liver: Other changes Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Other proteins | TOLED5 144,35,2003 |
intraperitoneal/guinea pig | lowest published toxic dose: 1974 mg/kg | Liver: Liver function tests impaired Liver: Other changes Biochemical: Metabolism (intermediary): Other | TOXID9 1,87,2001 |
intraperitoneal/mouse | lowest published toxic dose: 1870 mg/kg | Liver: Fatty liver degeneration | VCVGH* -,644,1990 |
intraperitoneal/mouse | lowest published toxic dose: 986.95 mg/kg | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | TOXID9 -,238,2009 |
intraperitoneal/mouse | lowest published toxic dose: 2960.85 mg/kg | Liver: Hepatitis (hepatocellular necrosis), zonal Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TOXID9 -,238,2009 |
intraperitoneal/mouse | lowest published toxic dose: 2961 mg/kg | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TOXID9 -,391,2009 |
intraperitoneal/rat | lowest published toxic dose: 1974 mg/kg | Liver: Other changes Reproductive: Paternal effects: Testes, epididymis, sperm duct Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | TOXID9 60,227,2001 |
intravenous/man | lowest published lethal dose: 129 mg/kg | Behavioral: General anesthetic Cardiac: Change in rate Lung, Thorax, or Respiration: Cyanosis | LANCAO 1,340,1982 |
oral/guinea pig | lethal dose (50 percent kill): 6 gm/kg | Behavioral: Excitement Behavioral: Antipsychotic | GTPZAB 24(3),36,1980 |
oral/guinea pig | lethal dose (50 percent kill): 6000 mg/kg | VCVGH* -,644,1990 | |
oral/rat | lethal dose (50 percent kill): 5680 mg/kg | Behavioral: Excitement Behavioral: Antipsychotic | GTPZAB 24(3),36,1980 |
oral/rat | lethal dose (50 percent kill): 5680 mg/kg | VCVGH* -,644,1990 | |
unreported route/woman | lowest published lethal dose: 0.4 mL/kg | Vascular: Regional or general arteriolar or venous dilation Blood: Hemorrhage | JFSCAS 45,923,2000 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/guinea pig | lowest published toxic concentration: 1 pph/4H/80D- intermittent | Liver: Other changes Immunological Including Allergic: Increase in cellular immune response Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases | TXAPA9 143,245,1997 |
inhalation/guinea pig | lowest published toxic concentration: 50 ppm/24H/5W- continuous | Liver: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain | ANESAV 42,408,1975 |
inhalation/guinea pig | lowest published toxic concentration: 10000 ppm/1H/7D- intermittent | Liver: Other changes Nutritional and Gross Metabolic: Conditioned vitamin deficiency Biochemical: Effect on specific coenzyme: Other coenzymes | JJATDK 9,9,1989 |
inhalation/mouse | lowest published toxic concentration: 300 ppm/24H/5W- continuous | Liver: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain | ANESAV 42,408,1975 |
inhalation/rat | lowest published toxic concentration: 200 mg/m3/16W- continuous | Immunological Including Allergic: Other immediate (humoral): uticaria, allergic rhinitis, serum sickness (multiple organ involvement) | VCVGH* -,645,1990 |
inhalation/rat | lowest published toxic concentration: 15 ppm/4H/9W- intermittent | Liver: Liver function tests impaired Reproductive: Paternal effects: Testes, epididymis, sperm duct Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) | TOLED5 144,105,2003 |
inhalation/rat | lowest published toxic concentration: 50 ppm/24H/4W- continuous | Liver: Hepatitis (hepatocellular necrosis), diffuse Liver: Fatty liver degeneration Liver: Changes in liver weight | PHTOEH 62,74,1988 |
inhalation/rat | lowest published toxic concentration: 10000 ppm/1H/7D- intermittent | Liver: Other changes Nutritional and Gross Metabolic: Conditioned vitamin deficiency | JJATDK 9,9,1989 |
inhalation/rat | lowest published toxic concentration: 300 ppm/24H/5W- continuous | Liver: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain | ANESAV 42,408,1975 |
inhalation/rat | lowest published toxic concentration: 2500 ppm/8H/8W- intermittent | Brain and Coverings: Other degenerative changes Kidney, Ureter, and Bladder: Urine volume increased Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites | EXNEAC 76,168,1982 |
inhalation/rat | lowest published toxic concentration: 5126 mg/m3/4H/17W- intermittent | Brain and Coverings: Recordings from specific areas of CNS Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase | GTPZAB 24(3),36,1980 |
inhalation/rat | lowest published toxic concentration: 500 ppm/6H/9D- intermittent | Gastrointestinal: Other changes Kidney, Ureter, and Bladder: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases | DTESD7 11,407,1983 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 50 ppm | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Not classifiable as a human carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Inadequate Evidence | IMSUDL 7,93,1987 |
TOXICOLOGY REVIEW | MUREAV 566,21,2004 | |
TOXICOLOGY REVIEW | INTEAG 15,7,1974 | |
TOXICOLOGY REVIEW | ARMCAH 25,411,1974 | |
TOXICOLOGY REVIEW | CJSUAX 15,217,1972 | |
TOXICOLOGY REVIEW | AASXAP 49,1,1971 | |
TOXICOLOGY REVIEW | AACRAT 57,328,1978 | |
TOXICOLOGY REVIEW | MUREAV 488,151,2001 | |
TOXICOLOGY REVIEW | TPHSDY 23,374,2002 | |
TOXICOLOGY REVIEW | TPHSDY 23,519,2002 | |
TOXICOLOGY REVIEW | CRTXB2 33,105,2003 | |
TOXICOLOGY REVIEW | TPHSDY 23,552,2002 | |
TOXICOLOGY REVIEW | EMMUEG 43,143,2004 | |
TOXICOLOGY REVIEW | TPHSDY 24,648,2003 | |
TOXICOLOGY REVIEW | AINCM* 7,63,2006 | |
TOXICOLOGY REVIEW | DIMON* 39,678,1993 | |
TOXICOLOGY REVIEW | ENTOX* -,125,2005 | |
TOXICOLOGY REVIEW | EJPHAZ 549,1,2006 | |
TOXICOLOGY REVIEW | HUTOX* -,577,1996 | |
TOXICOLOGY REVIEW | BLREV* 3,71,1989 | |
TOXICOLOGY REVIEW | CLLID* 13,277,2009 | |
TOXICOLOGY REVIEW | NCLNA* 16,503,1998 | |
TOXICOLOGY REVIEW | NEUCL* 18,695,2000 | |
TOXICOLOGY REVIEW | NEUCL* 23,397,2005 | |
TOXICOLOGY REVIEW | NBREV* 5,1,1981 | |
TOXICOLOGY REVIEW | MUREAV 721,27,2011 |
Standards and Regulations
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO HALOTHANE-air | ceiling concentration 2 ppm/60M | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 82943; Number of Industries 3; Total Number of Facilities 4118; Number of Occupations 15; Total Number of Employees Exposed 94682; Total Number of Female Employees Exposed 76108 | |
National Occupational Hazard Survey 1974 | Hazard Code 82943; Number of Industries 2; Total Number of Facilities 806; Number of Occupations 8; Total Number of Employees Exposed 9490 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division